When Is It Appropriate to Publish a Meta-Analysis in Cardiovascular Drugs and Therapy?

Charles Maynard, Salim Virani, Hani Jneid, Yochai Birnbaum

Internal Medicine

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Journal	Cardiovascular Drugs and Therapy
DOIs	https://doi.org/10.1007/s10557-023-07445-0
State	Accepted/In press - 2023

ASJC Scopus subject areas

Pharmacology
Cardiology and Cardiovascular Medicine
Pharmacology (medical)

Access to Document

10.1007/s10557-023-07445-0

Other files and links

Cite this

@article{622c8a5583e74588ab7abb6d2364bd0f,

title = "When Is It Appropriate to Publish a Meta-Analysis in Cardiovascular Drugs and Therapy?",

author = "Charles Maynard and Salim Virani and Hani Jneid and Yochai Birnbaum",

year = "2023",

doi = "10.1007/s10557-023-07445-0",

language = "English (US)",

journal = "Cardiovascular Drugs and Therapy",

issn = "0920-3206",

publisher = "Kluwer Academic Publishers",

}

TY - JOUR

T1 - When Is It Appropriate to Publish a Meta-Analysis in Cardiovascular Drugs and Therapy?

AU - Maynard, Charles

AU - Virani, Salim

AU - Jneid, Hani

AU - Birnbaum, Yochai

PY - 2023

Y1 - 2023

UR - http://www.scopus.com/inward/record.url?scp=85149024691&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85149024691&partnerID=8YFLogxK

U2 - 10.1007/s10557-023-07445-0

DO - 10.1007/s10557-023-07445-0

M3 - Editorial

C2 - 36847899

AN - SCOPUS:85149024691

SN - 0920-3206

JO - Cardiovascular Drugs and Therapy

JF - Cardiovascular Drugs and Therapy

ER -